ArticlePhysiological research2026
Peripubertal Exposure to Silver Nanoparticles (AgNPs) Triggers Follicle Activation, Probably Leading to "Burnout" by Stimulating the PI3K/AKT/mTOR/AMPK Signaling Pathway.
Article in Physiological research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the widespread use of silver nanoparticles (AgNPs) in consumer, industrial, and biomedical products, their potential effects on female reproductive health, particularly during critical developmental periods, remain insufficiently understood. The present study was therefore designed to investigate in vivo the dose-dependent effects of AgNP exposure on ovarian function and reproductive health in pubertal female rats. Pubertal Wistar albino female rats were divided into control and two AgNP groups (0.05 and 0.50 mg/kg/day). After one month of therapy, the females in the different groups were euthanized, and ovarian samples were collected. The results indicated that administration of AgNPs significantly increases the number of primordial follicles and significantly increases the number of growing follicles. Western blot analysis revealed that aromatase (Cyp19) and proliferating cell nuclear antigen (PCNA) were upregulated in both treatment groups. Similarly, the number of mRNA transcripts associated with folliculogenesis and steroidogenesis increased significantly in the high-dose treatment group. In addition, the level of growth differentiation factor 9 (GDF9) mRNA increased significantly in a dose-dependent manner. However, the levels of anti-Müllerian hormone (Amh) mRNA were considerably higher in the low-dose group and lower in the high-dose group, demonstrating that the detailed regulation of this gene is affected by AgNP dose. Analysis of the phosphatidylinositol 3-kinase signaling pathway revealed that compared to a 0.05 mg/kg, a AgNP exposure at 0.5 mg/kg significantly enhanced the PI3K/AKT/mTOR pathway and impacted Ampk signaling in a distinct manner. These findings suggest that AgNPs increase follicular development and deplete the follicular reserve, resulting in a phenomenon known as "burnout".
Indexed as
Identifiers
42708871PMC13580682What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.